-
- Verwendungszweck
- Leukotriene CysLT1 antagonist
- Reinheit
- >98 % (HPLC), NMR (Conforms)
- Chemical Name
- 1-[[[(1R)-1-[3-(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087
- Formel
- C35H35ClNO3S • Na
- Löslichkeit
- Soluble in DMSO (50 mg/ml), or water (30 mg/ml), or ethanol (60 mg/ml)
-
-
- Kommentare
-
Source: Synthetic. Appearance: Powder
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Handhabung
- Classification: D2A Very Toxic Material Causing Other Toxic Effects - Reproductive hazard E Corrosive Material - Corrosive to skin Hazard statement(s): H318 Causes serious eye damage. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. Precautionary statement(s): P280 Wear protective gloves/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- Lagerung
- -20 °C
-
- Molekulargewicht
- 608.2
- CAS-Nummer
- 151767-02-1
-
Sie sind hier:
